Perspectives of Women with Breast Cancer and Healthcare Providers Participating in an Adherence-Enhancing Program for Adjuvant Endocrine Therapy: A Qualitative Study
Background: Adjuvant endocrine therapy (AET) is prescribed for 5–10 years to women with hormone-sensitive breast cancer to prevent recurrence. However, a significant proportion of women do not adhere to AET. We developed SOIE, a one-year program designed to enhance the AET experience and adherence....
Saved in:
Main Authors: | Véronique Turcotte, Laurence Guillaumie, Martine Lemay, Anne Dionne, Julie Lemieux, Angéline Labbé, Carolyn Gotay, Line Guénette, Sophie Lauzier |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-01-01
|
Series: | Current Oncology |
Subjects: | |
Online Access: | https://www.mdpi.com/1718-7729/32/1/45 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Computational studies and structural insights for discovery of potential natural aromatase modulators for hormone-dependent breast cancer
by: Snehal Aditya Arvindekar, et al.
Published: (2024-09-01) -
Medication adherence and non-adherence in arterial hypertension: a narrative review
by: Claudio Tomasino, et al.
Published: (2025-01-01) -
Evidence-based cancer care: assessing guideline adherence of multidisciplinary tumor board recommendations for breast and colorectal cancer in a non-academic medical center
by: Carl-Stephan Leonhardt, et al.
Published: (2024-12-01) -
Strategies for preventing and managing osteoporosis in elderly breast cancer patients undergoing aromatase inhibitor therapy
by: Andi Tian, et al.
Published: (2025-01-01) -
Association between the aromatase (CYP19A1) gene variant rs10046 and cardiovascular risk in postmenopausal women
by: Betânia Rodrigues dos Santos, et al.
Published: (2025-01-01)